Cargando…
Single-cell profiling defines the prognostic benefit of CD39(high) tissue resident memory CD8+ T cells in luminal-like breast cancer
Luminal-like breast cancer (BC) constitutes the majority of BC subtypes, but, differently from highly aggressive triple negative BC, is poorly infiltrated by the immune system. The quality of the immune infiltrate in luminal-like BCs has been poorly studied, thereby limiting further investigation of...
Autores principales: | Losurdo, Agnese, Scirgolea, Caterina, Alvisi, Giorgia, Brummelman, Jolanda, Errico, Valentina, Di Tommaso, Luca, Pilipow, Karolina, Colombo, Federico Simone, Fernandes, Bethania, Peano, Clelia, Testori, Alberto, Tinterri, Corrado, Roncalli, Massimo, Santoro, Armando, Mazza, Emilia Maria Cristina, Lugli, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458450/ https://www.ncbi.nlm.nih.gov/pubmed/34552178 http://dx.doi.org/10.1038/s42003-021-02595-z |
Ejemplares similares
-
Author Correction: Single-cell profiling defines the prognostic benefit of CD39(high) tissue resident memory CD8+ T cells in luminal-like breast cancer
por: Losurdo, Agnese, et al.
Publicado: (2021) -
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice
por: Losurdo, Agnese, et al.
Publicado: (2020) -
CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression
por: Raschioni, Carlotta, et al.
Publicado: (2018) -
High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors
por: Brummelman, Jolanda, et al.
Publicado: (2018) -
Background fluorescence and spreading error are major contributors of variability in high‐dimensional flow cytometry data visualization by t‐distributed stochastic neighboring embedding
por: Mazza, Emilia Maria Cristina, et al.
Publicado: (2018)